Table 4.

Baseline characteristics with and without LEAD intervention

	No LEAD intervention n = 404	LEAD intervention n = 601	p
Age, y	70.1 ± 12.3	70.8 ± 11.0	0.365
Male, n (%)	234 (57.9)	362 (60.2)	0.464
BMI	25.50 ± 4.5	24.1 ± 4.5	<0.001
Male	25.1 ± 3.8	24.4 ± 4.0	0.025
Female	26.0 ± 5.3	23.8 ± 5.0	<0.001
<25, n (%)	199 (50.6)	368 (62.1)
25-<30, n (%)	136 (34.6)	172 (29.0)
Obesity
30-<35, n (%)	45 (11.5)	40 (6.7)
≥35, n (%)	13 (3.3)	13 (2.2)
Waist, cm	88.2 ± 13.0	87.5 ± 12.3	0.487
Male	88.9 ± 11.7	89.4 ± 11.7	0.676
Female	87.2 ± 15.0	84.4 ± 12.7	0.084
Hip, cm	96.6 ± 1.6	95.4 ± 10.1	0.172
Male	96.3 ± 10.9	96.4 ± 9.9	0.931
Female	97.0 ± 13.5	93.84 ± 10.3	0.035
Smoker, n (%)	150 (37.1)	258 (42.9)	0.066
Hypertension, n (%)	294 (72.8)	437 (78.7)	0.030
Diabetes, n (%)	273 (67.6)	412 (68.6)	0.744
Hypercholesterolemia, n (%)	299 (74)	431 (71.7)	0.423
Heart failure, n (%)	74 (18.3)	106 (17.7)	0.792
Coronary artery intervention, n (%)	110 (27.2)	217 (34.4)	0.465
Atrial fibrillation, n (%)	31 (7.7)	82 (13.6)	0.003
End-stage renal disease, n (%)	91 (22.5)	172 (18.6)	0.053

LEAD = lower extremity arterial disease.